I am/have/had
I am looking for
Advanced Filters
Found 1046 clinical trials
Study of CAbozantinib in Combination With AtezolizumaB for Muscle-Invasive BladdEr Cancer (ABATE)
This is an open-label phase II study assessing the activity of cabozantinib combined with atezolizumab in patients with resectable muscle-invasive urothelial carcinoma who are ineligible for cisplatin-based therapy or decline cisplatin-based therapy. Each cycle equals 21 days. The dose of atezolizumab is 1200 mg IV flat dose every 3 weeks …
metastasis
hiv test
cisplatin
gilbert's syndrome
hepatitis c
- 0 views
- 16 Feb, 2024
- 1 location
